We also found that the overall survival of 563 patients with TBX20 mutation was worse than 18,632 patients without TBX20 mutation in TCGA Pan-Cancer Resource (P = 9.04 × 10−4, log-rank test, Fig. 5a). Here, TBX20 is linked to cancer.